<DOC>
	<DOCNO>NCT01227421</DOCNO>
	<brief_summary>This randomize clinical trial design evaluate safety/efficacy two dosing regimen oral nitazoxanide compare placebo treatment acute uncomplicated influenza adult adolescent . The investigator hypothesize treatment Nitazoxanide reduce duration symptom patient confirm influenza infection . Secondarily , investigator hypothesize treatment nitazoxanide reduce complication influenza , severity symptom , time lose work , time return normal daily activity .</brief_summary>
	<brief_title>Safety Efficacy Study Nitazoxanide Treatment Acute Uncomplicated Influenza</brief_title>
	<detailed_description>A Randomized , Double-Blind , Placebo Controlled Study Nitazoxanide Adults Adolescents Acute Uncomplicated Influenza . The primary objective study demonstrate efficacy nitazoxanide administer 300 mg two time per day 5 day 600 mg two time per day 5 day reduce time resolution clinical symptom influenza . The study also evaluate pharmacokinetics nitazoxanide subset 24 patient safety nitazoxanide regimen compare placebo via analysis adverse event laboratory safety test . Blood sample collect patient baseline , day 7 day 28 , subset 24 patient age 18-65 year ( pharmacokinetics subset ) day 2 . Urine sample collect baseline day 7 . Nasal swabs collect baseline day 7 patient day 2 , 3 , 4 5 subset patient ( approximately 20 % patient ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>INCLUSION CRITERIA age 12 65 year Presence clinical sign , respiratory symptom constitutional symptom compatible influenza infection : 1. fever , 2. least one follow respiratory symptom : cough , sore throat , nasal discharge , nasal congestion , sneeze . 3 . At least one follow constitutional symptom : headache , myalgia , seat , chill , fatigue severity ( mild , moderate , severe ) Confirmation Influenza A B infection local community Onset illness 48 hour presentation . Time onset illness define either early ( 1 ) time temperature first measure elevate , ( 2 ) time patient experience presence least one respiratory symptom AND presence least one constitutional symptom . willing able comply protocol requirement provide informed consent EXCLUSION CRITERIA : severity illness require anticipate require inhospital care High risk complication influenza follow : 1. person asthma chronic pulmonary disease 2. person hemodynamically significant cardiac disease 3. person immunosuppressive disorder receive immunosuppressive therapy 4. person infect Human Immunodeficiency Virus ( HIV ) 5. person sickle cell anemia hemoglobinopathies 6. person disease require longterm aspirin therapy 7. person chronic renal dysfunction 8. person liver disorder 9 . Persons cancer 10 . Persons chronic metabolic disease diabetes inherit mitochondrial disorder 11 . Persons neuromuscular disorder , seizure disorder , cognitive dysfunction 12 . Residents age nursing home longterm institution . Females child bear age pregnant , breastfeed sexually active without birth control vaccination influenza H1N1 ( Swine Flu ) August 1 , 2010 treatment antiviral medication oseltamivir , zanamivir , amantadine , rimantadine within 30 day screen . Prior treatment nitazoxanide within 30 day prior screen . subject active respiratory allergy expect require antiallergy medication study period . know sensitivity nitazoxanide subject unable take oral medication subject chronic kidney liver disease Presence preexisting chronic infection undergo require medical therapy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>influenza</keyword>
</DOC>